Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma

被引：20
作者：
Claps, Melanie [1 ]
Cerri, Sara [1 ]
Grisanti, Salvatore [1 ]
Lazzari, Barbara [1 ]
Ferrari, Vittorio [1 ]
Roca, Elisa [1 ]
Perotti, Paola [2 ]
Terzolo, Massimo [2 ]
Sigala, Sandra [3 ]
Berruti, Alfredo [1 ]
机构：
[1] Univ Brescia, ASST Spedali Civili Brescia, Dept Med & Surg Specialties Radiol Sci & Publ Hlt, Oncol Unit, Brescia, Italy
[2] Univ Turin, S Luigi Hosp, Dept Clin & Biol Sci, Internal Med 1, Turin, Italy
[3] Univ Brescia, Pharmacol Sect, Dept Mol & Translat Med, Brescia, Italy
来源：
ENDOCRINE | 2018年 / 61卷 / 01期
关键词：
MANAGEMENT; MULTICENTER; CANCER;
D O I：
10.1007/s12020-017-1428-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：169 / 172
页数：4
相关论文
共 16 条
  • [1] Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial
    Berruti, A
    Terzolo, M
    Sperone, P
    Pia, A
    Della Casa, S
    Gross, DJ
    Carnaghi, C
    Casali, P
    Porpiglia, F
    Mantero, F
    Reimondo, G
    Angeli, A
    Dogliotti, L
    [J]. ENDOCRINE-RELATED CANCER, 2005, 12 (03) : 657 - 666
  • [2] Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
    Berruti, A.
    Baudin, E.
    Gelderblom, H.
    Haak, H. R.
    Porpiglia, F.
    Fassnacht, M.
    Pentheroudakis, G.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 131 - 138
  • [3] Prognostic Role of Overt Hypercortisolism in Completely Operated Patients with Adrenocortical Cancer
    Berruti, Alfredo
    Fassnacht, Martin
    Haak, Harm
    Else, Tobias
    Baudin, Eric
    Sperone, Paola
    Kroiss, Matthias
    Kerkhofs, Thomas
    Williams, Andrew R.
    Ardito, Arianna
    Leboulleux, Sophie
    Volante, Marco
    Deutschbein, Timo
    Feelders, Richards
    Ronchi, Cristina
    Grisanti, Salvatore
    Gelderblom, Hans
    Porpiglia, Francesco
    Papotti, Mauro
    Hammer, Gary D.
    Allolio, Bruno
    Terzolo, Massimo
    [J]. EUROPEAN UROLOGY, 2014, 65 (04) : 832 - 838
  • [4] Effectiveness of Metyrapone in Treating Cushing's Syndrome: A Retrospective Multicenter Study in 195 Patients
    Daniel, Eleni
    Aylwin, Simon
    Mustafa, Omar
    Ball, Steve
    Munir, Atif
    Boelaert, Kristien
    Chortis, Vasileios
    Cuthbertson, Daniel J.
    Daousi, Christina
    Rajeev, Surya P.
    Davis, Julian
    Cheer, Kelly
    Drake, William
    Gunganah, Kirun
    Grossman, Ashley
    Gurnell, Mark
    Powlson, Andrew S.
    Karavitaki, Niki
    Huguet, Isabel
    Kearney, Tara
    Mohit, Kumar
    Meeran, Karim
    Hill, Neil
    Rees, Aled
    Lansdown, Andrew J.
    Trainer, Peter J.
    Minder, Anna-Elisabeth H.
    Newell-Price, John
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2015, 100 (11) : 4146 - 4154
  • [5] Combination Chemotherapy in Advanced Adrenocortical Carcinoma
    Fassnacht, Martin
    Terzolo, Massimo
    Allolio, Bruno
    Baudin, Eric
    Haak, Harm
    Berruti, Alfredo
    Welin, Staffan
    Schade-Brittinger, Carmen
    Lacroix, Andre
    Jarzab, Barbara
    Sorbye, Halfdan
    Torpy, David J.
    Stepan, Vinzenz
    Schteingart, David E.
    Arlt, Wiebke
    Kroiss, Matthias
    Leboulleux, Sophie
    Sperone, Paola
    Sundin, Anders
    Hermsen, Ilse
    Hahner, Stefanie
    Willenberg, Holger S.
    Tabarin, Antoine
    Quinkler, Marcus
    de la Fouchardiere, Christelle
    Schlumberger, Martin
    Mantero, Franco
    Weismann, Dirk
    Beuschlein, Felix
    Gelderblom, Hans
    Wilmink, Hanneke
    Sender, Monica
    Edgerly, Maureen
    Kenn, Werner
    Fojo, Tito
    Muller, Hans-Helge
    Skogseid, Britt
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (23) : 2189 - 2197
  • [6] PHARMACOKINETIC CONSEQUENCES AND TOXICOLOGIC IMPLICATIONS OF METYRAPONE-INDUCED ALTERATIONS OF ACETAMINOPHEN ELIMINATION IN MAN
    GALINSKY, RE
    NELSON, EB
    ROLLINS, DE
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 33 (04) : 391 - 396
  • [7] Hahner Stefanie, 2005, Curr Opin Investig Drugs, V6, P386
  • [8] Plasma Concentrations of o,p′DDD, o,p′DDA, and o,p′DDE as Predictors of Tumor Response to Mitotane in Adrenocortical Carcinoma: Results of a Retrospective ENS@T Multicenter Study
    Hermsen, Ilse G.
    Fassnacht, Martin
    Terzolo, Massimo
    Houterman, Saskia
    den Hartigh, Jan
    Leboulleux, Sophie
    Daffara, Fulvia
    Berruti, Alfredo
    Chadarevian, Rita
    Schlumberger, Martin
    Allolio, Bruno
    Haak, Harm R.
    Baudin, Eric
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (06) : 1844 - 1851
  • [9] Drug interactions with mitotane by induction of CYP3A4 metabolism in the clinical management of adrenocortical carcinoma
    Kroiss, Matthias
    Quinkler, Marcus
    Lutz, Werner K.
    Allolio, Bruno
    Fassnach, Martin
    [J]. CLINICAL ENDOCRINOLOGY, 2011, 75 (05) : 585 - 591
  • [10] Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma
    Malandrino, Pasqualino
    Al Ghuzlan, Abir
    Castaing, Marine
    Young, Jacques
    Caillou, Bernard
    Travagli, Jean-Paul
    Elias, Dominique
    de Baere, Thierry
    Dromain, Clarisse
    Paci, Angelo
    Chanson, Philippe
    Schlumberger, Martin
    Leboulleux, Sophie
    Baudin, Eric
    [J]. ENDOCRINE-RELATED CANCER, 2010, 17 (03) : 797 - 807
12